Current Affairs - Science - Discussion

Discussion Forum : Science - Latest Current Affairs (Q.No. 408)
408.
Who has approved Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine, COVISHIELD, in India?
DARPG
CSIR
ICMR
DCGI
Answer: Option
Explanation:
The Drugs Controller General of India (DCGI) has approved Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine, COVISHIELD, in India by the Serum Institute of India, Pune. The move is to hasten the development of the COVID-19 vaccine
Discussion:
Be the first person to comment on this question !

Post your comments here:

Your comments will be displayed after verification.